{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:57:22Z","timestamp":1791910642792,"version":"4.3.4"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T00:00:00Z","timestamp":1666137600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["ES027353"],"award-info":[{"award-number":["ES027353"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Autoimmune diseases can be triggered by environmental toxicants such as crystalline silica dust (cSiO<jats:sub>2<\/jats:sub>). Here, we characterized the dose-dependent immunomodulation and toxicity of the glucocorticoid (GC) prednisone in a preclinical model that emulates onset and progression of cSiO<jats:sub>2<\/jats:sub>-triggered lupus. Two cohorts of 6-wk-old female NZBWF1 mice were fed either control AIN-93G diet or one of three AIN-93G diets containing prednisone at 5, 15, or 50 mg\/kg diet which span human equivalent oral doses (HED) currently considered to be low (PL; 5 mg\/d HED), moderate (PM; 14 mg\/d HED), or high (PH; 46 mg\/d HED), respectively. At 8 wk of age, mice were intranasally instilled with either saline vehicle or 1 mg cSiO<jats:sub>2<\/jats:sub> once weekly for 4 wk. The experimental plan was to 1) terminate one cohort of mice (n=8\/group) 14 wk after the last cSiO<jats:sub>2<\/jats:sub> instillation for pathology and autoimmunity assessment and 2) to maintain a second cohort (n=9\/group) to monitor glomerulonephritis development and survival. Mean blood concentrations of prednisone\u2019s principal active metabolite, prednisolone, in mice fed PL, PM, and PH diets were 27, 105, 151 ng\/ml, respectively, which are consistent with levels observed in human blood \u2264 12 h after single bolus treatments with equivalent prednisone doses. Results from the first cohort revealed that consumption of PM, but not PL diet, significantly reduced cSiO<jats:sub>2<\/jats:sub>-induced pulmonary ectopic lymphoid structure formation, nuclear-specific AAb production, inflammation\/autoimmune gene expression in the lung and kidney, splenomegaly, and glomerulonephritis in the kidney. Relative to GC-associated toxicity, PM diet, but not PL diet, elicited muscle wasting, but these diets did not affect bone density or cause glucosuria. Importantly, neither PM nor PL diet improved latency of cSiO<jats:sub>2<\/jats:sub>-accelerated death. PH-fed mice in both cohorts displayed robust GC-associated toxicity including body weight loss, reduced muscle mass, and extensive glucosuria 7 wk after the final cSiO<jats:sub>2<\/jats:sub> instillation requiring their early removal from the study. Taken together, our results demonstrate that while moderate doses of prednisone can reduce important pathological endpoints of cSiO<jats:sub>2<\/jats:sub>-induced autoimmunity in lupus-prone mice, such as upstream ectopic lymphoid structure formation, these ameliorative effects come with unwanted GC toxicity, and, crucially, none of these three doses extended survival time.<\/jats:p>","DOI":"10.3389\/fimmu.2022.972108","type":"journal-article","created":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T17:51:04Z","timestamp":1666201864000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Comparative effects of human-equivalent low, moderate, and high dose oral prednisone intake on autoimmunity and glucocorticoid-related toxicity in a murine model of environmental-triggered lupus"],"prefix":"10.3389","volume":"13","author":[{"given":"Lauren K.","family":"Heine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abby D.","family":"Benninghoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lichchavi D.","family":"Rajasinghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan P.","family":"Lewandowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexa L.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan-Zhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Buchweitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Zyskowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashleigh N.","family":"Tindle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna E.","family":"Skedel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Chargo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura R.","family":"McCabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack R.","family":"Harkema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Pestka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00228","article-title":"Mechanisms of autoantibody production in systemic lupus erythematosus","volume":"228","author":"Han","year":"2015","journal-title":"Front Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2018.11.001","article-title":"Systemic lupus erythematosus: Diagnosis and clinical management","volume":"96","author":"Fava","year":"2019","journal-title":"Acad Press"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00475","article-title":"Mechanisms of kidney injury in lupus nephritis - the role of anti-dsdna antibodies","volume":"6","author":"Yung","year":"2015","journal-title":"Front Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2017.05.006","article-title":"Pathogenesis of human systemic lupus erythematosus: A cellular perspective","volume":"23","author":"Moulton","year":"2017","journal-title":"Trends Mol Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/s41467-021-21049-y","article-title":"Identification of 38 novel loci for systemic lupus erythematosus and genetic heterogeneity between ancestral groups","volume":"12","author":"Wang","year":"2021","journal-title":"Nat Commun"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2017.09.005","article-title":"Understanding the role of environmental factors in the development of systemic lupus erythematosus","volume":"31","author":"Parks","year":"2017","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s11926-016-0562-3","article-title":"What causes lupus flares","volume":"18","author":"Fernandez","year":"2016","journal-title":"Curr Rheumatol Rep"},{"key":"B8","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1289\/ehp.99107s5793","article-title":"Occupational exposure to crystalline silica and autoimmune disease","author":"Parks","year":"1999","journal-title":"Environ Health Perspect"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1080\/15476910490911922","article-title":"Silica, apoptosis, and autoimmunity","volume":"1","author":"Brown","year":"2005","journal-title":"J Immunotoxicol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/all.14202","article-title":"Silica-related diseases in the modern world","volume":"75","author":"Hoy","year":"2020","journal-title":"Allergy"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1177\/0192623319878398","article-title":"Lupus, silica, and dietary omega-3 fatty acid interventions","volume":"47","author":"Wierenga","year":"2019","journal-title":"Toxicol Pathol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/271694","article-title":"Murine Models of Systemic Lupus Erythematosus","volume":"2011","author":"Perry","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0125481","article-title":"Silica triggers inflammation and ectopic lymphoid neogenesis in the lungs in parallel with accelerated onset of systemic autoimmunity and glomerulonephritis in the lupus-prone Nzbwf1 mouse","volume":"10","author":"Bates","year":"2015","journal-title":"PloS One"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e0160622","DOI":"10.1371\/journal.pone.0160622","article-title":"Silica-triggered autoimmunity in lupus-prone mice blocked by docosahexaenoic acid consumption","volume":"11","author":"Bates","year":"2016","journal-title":"PloS One"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2016.217","article-title":"Ectopic Lymphoid Neogenesis in Rheumatic Autoimmune Diseases","volume":"13","author":"Bombardieri","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.653464","article-title":"Omega-3 polyunsaturated fatty acid intervention against established autoimmunity in a murine model of toxicant-triggered lupus","volume":"12","author":"Pestka","year":"2021","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02851","article-title":"Docosahexaenoic acid consumption impedes early interferon- and chemokine-related gene expression while suppressing silica-triggered flaring of murine lupus","volume":"10","author":"Benninghoff","year":"2019","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1080\/08916934.2020.1801651","article-title":"Omega-3 fatty acid intake suppresses induction of diverse autoantibody repertoire by crystalline silica in lupus-prone mice","volume":"53","author":"Rajasinghe","year":"2020","journal-title":"Autoimmunity"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0233183","article-title":"Influence of total Western diet on docosahexaenoic acid suppression of silica-triggered lupus flaring in Nzbwf1 mice","volume":"15","author":"Gilley","year":"2020","journal-title":"PloS One"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2019-000916","article-title":"Glucocorticoid withdrawal in systemic lupus erythematosus: Are remission and low disease activity reliable starting points for stopping treatment? a real-life experience","volume":"5","author":"Tani","year":"2019","journal-title":"RMD Open"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9092709","article-title":"Glucocorticoids in systemic lupus erythematosus. Ten questions and some issues","volume":"9","author":"Porta","year":"2020","journal-title":"J Clin Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1210\/me.2011-0068","article-title":"Minireview: Glucocorticoids in autoimmunity: Unexpected targets and mechanisms","volume":"25","author":"Flammer","year":"2011","journal-title":"Mol Endocrinol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.1","article-title":"Immune regulation by glucocorticoids","volume":"17","author":"Cain","year":"2017","journal-title":"Nat Publ Group"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000527","article-title":"Glucocorticoids and antimalarials in systemic lupus erythematosus: An update and future directions","volume":"30","author":"Ugarte","year":"2018","journal-title":"NLM (Medline)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2020.03.008","article-title":"Is it possible to stop glucocorticoids in systemic lupus","volume":"87","author":"Felten","year":"2020","journal-title":"Elsevier Masson SAS"},{"key":"B26","article-title":"Belimumab (Benlysta): A breakthrough therapy for systemic lupus erythematosus","volume":"37","author":"Lamore","year":"2012","journal-title":"P T"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1136\/ard.61.8.718","article-title":"Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: Current questions and tentative answers in rheumatology","volume":"61","author":"Buttgereit","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216303","article-title":"Withdrawal of low-dose prednisone in sle patients with a clinically quiescent disease for more than 1 year: A randomised clinical trial","volume":"79","author":"Mathian","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2015.05.011","article-title":"Comparison of high versus low-medium prednisone doses for the treatment of systemic lupus erythematosus patients with high activity at diagnosis","volume":"14","author":"Ruiz-Arruza","year":"2015","journal-title":"Elsevier"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2014-000066","article-title":"Effect of corticosteroid use by dose on the risk of developing organ damage over time in systemic lupus erythematosus-the Hopkins lupus cohort","volume":"2","author":"Al Sawah","year":"2015","journal-title":"Lupus Sci Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.080828","article-title":"Prednisone, lupus activity, and permanent organ damage","volume":"36","author":"Thamer","year":"2009","journal-title":"J Rheumatol"},{"key":"B32","first-page":"1","article-title":"Anthropometric reference data for children and adults: United states, 2015-2018","volume":"3","author":"Fryar","year":"2021","journal-title":"Vital Health Stat 3"},{"key":"B33","first-page":"14","article-title":"Approximate relation of parts per million in the diet to mg\/kg\/day (table)","volume":"18","author":"Nelson","year":"1954","journal-title":"Assoc Food Drug Officials Quart Bull"},{"key":"B34","article-title":"Estimating the safe starting dose in clinical trials for therapeutics in adult healthy volunteers","volume":"1","year":"2005","journal-title":"U.S. Dep Health Hum Serv"},{"key":"B35","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1177\/019262339202000103","article-title":"Prednisone is not a mouse carcinogen","volume":"20","author":"Dillberger","year":"1992","journal-title":"Toxicol Pathol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1186\/1743-8977-10-26","article-title":"Engineered silica nanoparticles act as adjuvants to enhance allergic airway disease in mice","volume":"10","author":"Brandenberger","year":"2013","journal-title":"Part Fibre Toxicol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.201000640","article-title":"Body composition and hormonal effects following exposure to mycotoxin deoxynivalenol in the high-fat diet-induced obese mouse","volume":"55","author":"Kobayashi-Hattori","year":"2011","journal-title":"Mol Nutr Food Res"},{"key":"B38","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1365-2818.2010.03481.x","article-title":"A simple tool for stereological assessment of digital images","volume":"243","author":"Tschanz","year":"2011","journal-title":"Stepanizer J Microsc"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1097\/01.asn.0000108969.21691.5d","article-title":"The classification of glomerulonephritis in systemic lupus erythematosus revisited","volume":"15","author":"Weening","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv468","article-title":"Clustvis: A web tool for visualizing clustering of multivariate data using principal component analysis and heatmap","volume":"43","author":"Metsalu","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00632","article-title":"Mapping of dynamic transcriptome changes associated with silica-triggered autoimmune pathogenesis in the lupus-prone NZBWF1 mouse","volume":"10","author":"Bates","year":"2019","journal-title":"Front Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/nu12020544","article-title":"Consumption of the total Western diet promotes colitis and inflammation-associated colorectal cancer in mice","volume":"12","author":"Benninghoff","year":"2020","journal-title":"Nutrients"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-9-488","article-title":"Biovenn - a web application for the comparison and visualization of biological lists using area-proportional Venn diagrams","volume":"9","author":"Hulsen","year":"2008","journal-title":"BMC Genomics"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-017-0215-8","article-title":"Gene expression markers of tumor infiltrating leukocytes","volume":"5","author":"Danaher","year":"2017","journal-title":"J Immunother Cancer"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3947","article-title":"Involvement of the gut microbiota and barrier function in glucocorticoid-induced osteoporosis","volume":"35","author":"Schepper","year":"2020","journal-title":"J Bone Miner Res"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034204","article-title":"Glucocorticoid-treated mice are an inappropriate positive control for long-term preclinical studies in the mdx mouse","volume":"7","author":"Sali","year":"2012","journal-title":"PloS One"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2011.09.015","article-title":"Pharmacokinetics of prednisolone at steady state in young patients with systemic lupus erythematosus on prednisone therapy: An open-label, single-dose study","volume":"33","author":"Sagcal-Gironella","year":"2011","journal-title":"Clin Ther"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/aps.2015.76","article-title":"Prednisone treatment inhibits the differentiation of b lymphocytes into plasma cells in Mrl\/Mpslac-lpr mice","volume":"36","author":"Yan","year":"2015","journal-title":"Acta Pharmacol Sin"},{"key":"B49","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1254\/jphs.fp0071337","article-title":"Microarray analysis of glomerular gene expression in murine lupus nephritis","volume":"106","author":"Teramoto","year":"2008","journal-title":"J Pharmacol Sci"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1210\/en.2011-1891","article-title":"Chronic prednisolone treatment aggravates hyperglycemia in mice fed a high-fat diet but does not worsen dietary fat-induced insulin resistance","volume":"153","author":"Laskewitz","year":"2012","journal-title":"Endocrinology"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1111\/fcp.12515","article-title":"Free prednisolone pharmacokinetics predicted from total concentrations in patients with inflammatory - immunonologic conditions","volume":"34","author":"Mangin","year":"2020","journal-title":"Fundam Clin Pharmacol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/321359","article-title":"Serology of lupus erythematosus: Correlation between immunopathological features and clinical aspects","volume":"2014","author":"Cozzani","year":"2014","journal-title":"Autoimmune Dis"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.6.556","article-title":"Anti-dsdna, anti-Sm antibodies, and the lupus anticoagulant: Significant factors associated with lupus nephritis","volume":"62","author":"Alba","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00464-0","article-title":"Glucocorticoids in T cell development, differentiation and function","volume":"21","author":"Taves","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02336","article-title":"Silica exposure differentially modulates autoimmunity in lupus strains and autoantibody transgenic mice","volume":"10","author":"Foster","year":"2019","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.972108\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T17:51:11Z","timestamp":1666201871000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.972108\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,19]]},"references-count":55,"alternative-id":["10.3389\/fimmu.2022.972108"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.972108","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,19]]},"article-number":"972108"}}